OR WAIT null SECS
April 27, 2021
Sanofi will perform the fill/finish of up to 200 million doses of Moderna’s COVID-19 vaccine at its Ridgefield, NJ, facility starting in September 2021.
April 19, 2021
Material properties play a role in container closure integrity under frozen or cryogenic storage temperatures.
April 06, 2021
Under the terms of the expanded agreement, Catalent will provide Moderna with a new high-speed vial filling line until June 2023 along with inspection, labeling, cartoning, and final packaging for potential pipeline programs.
April 03, 2021
Intensified and distributed manufacturing approaches create flexible, local capacity.
Although vials and prefilled syringes have different advantages, both find use in vaccine fill/finish.
March 30, 2021
The expanded agreement will include aseptic fill/finish services at its San Diego, CA facility.
March 08, 2021
Manufacturing of the vaccine will take place at Baxter’s fill/finish sterile manufacturing facilities located in Bloomington, IN.
February 02, 2021
CDMOs address the unique challenges of liquid and lyophilized forms as well as preparing for the large capacity needed for COVID-19 vaccines.
February 01, 2021
Cytiva acquired Vanrx Pharmasystems, a Canadian manufacturer of robotic aseptic filling equipment.
January 26, 2021
Clinical material for a Theratechnologies product in development will be produced at PPS’ manufacturing facility in Lexington, KY.